Q2 2016 Holdings
Filed 2016-08-16 | 54 holdings | $97.4M | 13F-HR | View on SEC ↗ · Holdings Table ↗
Sign in to see sub-manager breakdown
| Issuer | Class | CUSIP | Value ↓ | Shares | % Portfolio |
|---|---|---|---|---|---|
| Boston Scientific Corp(BSX) | COM | 101137107 | $28.8M | 1,230,320 | 29.5% |
| Biomarin Pharmaceutical Inc(BMRN) | COM | 09061G101 | $25.1M | 322,394 | 25.8% |
| Brookdale SR Living Inc(BKD) | COM | 112463104 | $23.9M | 1,545,331 | 24.5% |
| Charles RIV Labs Intl Inc(CRL) | COM | 159864107 | $10.9M | 131,606 | 11.1% |
| Cytomx Therapeutics Inc(CTMX) | COM | 23284F105 | $7.5M | 733,899 | 7.7% |
| Biogen Inc(BIIB) | COM | 09062X103 | $297.0K | 1,229 | 0.3% |
| Aurinia Pharmaceuticals Inc(AUPH) | COM | 05156V102 | $79.0K | 28,410 | 0.1% |
| Array Biopharma Inc(ARRYEUR) | COM | 04269X105 | $68.2K | 19,150,650 | 0.1% |
| Amicus Therapeutics Inc(FOLD) | COM | 03152W109 | $60.6K | 11,106,446 | 0.1% |
| Medivation Inc | COM | 58501N101 | $56.1K | 929,529 | 0.1% |
| Seattle Genetics Inc | COM | 812578102 | $55.8K | 1,381,477 | 0.1% |
| Atara Biotherapeutics Inc(ATRAGBX) | COM | 046513107 | $54.2K | 2,408,970 | 0.1% |
| Penumbra Inc(PEN) | COM | 70975L107 | $51.4K | 863,581 | 0.1% |
| Endologix Inc | COM | 29266S106 | $49.4K | 3,962,753 | 0.1% |
| Clovis Oncology Inc(CLVSEUR) | COM | 189464100 | $42.5K | 3,097,850 | 0.0% |
| Molina Healthcare Inc(MOH) | COM | 60855R100 | $42.2K | 845,360 | 0.0% |
| Intra Cellular Therapies Inc(ITCIEUR) | COM | 46116X101 | $37.7K | 971,565 | 0.0% |
| Portola Pharmaceuticals Inc | COM | 737010108 | $34.6K | 1,466,537 | 0.0% |
| Nevro Corp(NVROEUR) | COM | 64157F103 | $29.4K | 398,371 | 0.0% |
| Spdr Series Trust(XBI) | S&P BIOTECH | 78464A870 | $26.6K | 490,900 | 0.0% |
| Model N Inc(MODNEUR) | COM | 607525102 | $25.4K | 1,900,659 | 0.0% |
| Nanostring Technologies Inc(NSTGEUR) | COM | 63009R109 | $24.6K | 1,949,185 | 0.0% |
| Incyte Corp(INCY) | COM | 45337C102 | $24.2K | 302,307 | 0.0% |
| Alexion Pharmaceuticals Inc(ALXN) | COM | 015351109 | $23.6K | 202,400 | 0.0% |
| Heartware Intl Inc | COM | 422368100 | $23.4K | 405,497 | 0.0% |
| Wave Life Sciences LTD(WVE) | SHS | Y95308105 | $22.7K | 1,095,473 | 0.0% |
| Aetna Inc New | COM | 00817Y108 | $22.4K | 183,225 | 0.0% |
| Centene Corp del(CNC) | COM | 15135B101 | $20.4K | 285,143 | 0.0% |
| Prothena Corp PLC(PRTA) | SHS | G72800108 | $17.0K | 487,406 | 0.0% |
| Syros Pharmaceuticals Inc | COM | 87184Q107 | $15.1K | 946,182 | 0.0% |
| Neuroderm LTD | ORD SHS | M74231107 | $13.3K | 821,445 | 0.0% |
| Chimerix Inc(CMRXEUR) | COM | 16934W106 | $12.9K | 3,288,376 | 0.0% |
| Oxford Immunotec Global PLC | ORD SHS | G6855A103 | $12.9K | 1,428,094 | 0.0% |
| Adeptus Health Inc(ADPTEUR) | CL A | 006855100 | $8.4K | 163,474 | 0.0% |
| Press Ganey Hldgs Inc | COM | 74113L102 | $7.8K | 198,214 | 0.0% |
| Spectranetics Corp | COM | 84760C107 | $7.5K | 401,836 | 0.0% |
| Conformis Inc(CFMS) | COM | 20717E101 | $7.4K | 1,047,821 | 0.0% |
| Envision Healthcare Hldgs in | COM | 29413U103 | $7.3K | 288,918 | 0.0% |
| Pharmerica Corp | COM | 71714F104 | $6.5K | 263,862 | 0.0% |
| VCA Inc | COM | 918194101 | $6.4K | 94,200 | 0.0% |
| Ehealth Inc(EHTH) | COM | 28238P109 | $6.0K | 426,242 | 0.0% |
| Ironwood Pharmaceuticals Inc(IRWD) | COM CL A | 46333X108 | $5.8K | 442,711 | 0.0% |
| American Renal Associates HO(ARAUSD) | COM | 029227105 | $4.3K | 149,900 | 0.0% |
| Invitae Corp(NVTA1EUR) | COM | 46185L103 | $4.0K | 544,939 | 0.0% |
| Array Biopharma Inc | NOTE 3.000% 6/0 | 04269XAA3 | $3.4K | $4,000,000 | 0.0% |
| Proqr Thrapeutics N V | SHS EURO | N71542109 | $2.8K | 581,638 | 0.0% |
| Fate Therapeutics Inc(FATE) | COM | 31189P102 | $2.6K | 1,502,180 | 0.0% |
| Syndax Pharmaceuticals Inc(SNDX) | COM | 87164F105 | $2.5K | 250,830 | 0.0% |
| Blueprint Medicines Corp(2L9) | COM | 09627Y109 | $574 | 28,353 | 0.0% |
| Axovant Sciences LTD | COM | G0750W104 | $321 | 25,000 | 0.0% |